By resolution of the Board of Directors on February 6, 2025, EGC Therapeutics, Inc. appointed Chief Operating Officer Sanghyuk Suh and Chief Technology Officer Nathaniel S. Hwang as Co-Chief Executive Officers. Byung-Gee Kim, the former Chief Executive Officer, was appointed Chairman of the Board of Directors.